Back to company

NORDIC PHARMACEUTICALS ApS: Financial statements 2019

CVR: 27430015

NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,268,578 and a net result of DKK 25,941 compared with DKK 34,298 the year before. That is an increase of 19.3% compared with the year before. Equity amounted to DKK 1,289,438. The solvency ratio was 41.3%. The company had 3 employees in the financial year.

Gross Profit
1,268,578 kr.
Profit/Loss
25,941 kr.
Equity
1,289,438 kr.
Total Assets
3,125,821 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.3 mio.26 t.1.3 mio.3
2018-1.1 mio.34 t.1.3 mio.3
2017-1 mio.40 t.1.2 mio.3
2016-1.4 mio.145 t.1.2 mio.3
2015-1.3 mio.282 t.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

NORDIC PHARMACEUTICALS ApS: The 2018 annual report is outJun 25, 2019

NORDIC PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK 1,062,911, and the net result was DKK 34,298.

About NORDIC PHARMACEUTICALS ApS

NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 3 employees. In 2024, the company reported a gross profit of DKK -2,243,265 and a net result of DKK -2,664,416 compared with DKK 9,351 the year before. Equity amounted to DKK -1,152,541.